Wendy A. Thomas - Concepedia

Concepedia

Author

Wendy A. Thomas

University of Birmingham

Also Known As

W A Thomas, Wendy A Thomas, Wendy A. Thomas, Wendy A. Thomas (190718), Wendy Thomas

23

Publications

2.3K

Citations

17

H-Index

25

Concepts

All Affiliations

University of Birmingham Cancer Research UK Clinical Trials Unit Cancer Research UK Heartlands Hospital

WA

About

Wendy A. Thomas is an author at University of Birmingham specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Immunology	7	7	1.1K
3	Cell Biology	5	5	926
4	Pathology	4	4	386
5	Allergy	2	2	606

Wendy A. Thomas

×

17

Publications

2.3K

Citations

17

H-Index

	Year	Citations
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. R J Murray, Michael G. Kurilla, Jill Brooks, The Journal of Experimental Medicine Target AntigensImmunologyAntigen ProcessingCd4 T Cell ResponsesImmune System	1992	505
Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy S P Lee, Rosemary J. Tierney, Wendy A. Thomas, The Journal of Immunology	1997	207
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation Jianmin Zuo, Andrew Currin, Bryan D. Griffin, PLoS Pathogens	2009	196
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 S P Lee, Wendy A. Thomas, R J Murray, Journal of Virology	1993	181
An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link Gemma L. Kelly, Heather M. Long, Julianna Stylianou, PLoS Pathogens Lymphoid NeoplasiaWp/bhrf1 LinkTransformed CellsEpstein-barr VirusImmunology	2009	169
CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1 Steven P. Lee, Jill Brooks, Hatim Al-Jarrah, The Journal of Experimental Medicine	2004	154
CTL Control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-Specific CTL Responses in the Blood and Tumors of NPC Patients and the Antigen-Processing Function of the Tumor Cells Steven P. Lee, Anthony T.�C. Chan, Wendy A. Thomas, The Journal of Immunology	2000	117
Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation Richard Amoroso, Leah Fitzsimmons, Wendy A. Thomas, Journal of Virology	2010	110
Antigen Presenting Phenotype of Hodgkin Reed-Sternberg Cells: Analysis of the HLA Class I Processing Pathway and the Effects of Interleukin-10 on Epstein-Barr Virus-Specific Cytotoxic T-Cell Recognition Steven P. Lee, Christothea M. Constandinou, Wendy A. Thomas, Blood	1998	106
Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. Jill Brooks, R J Murray, Wendy A. Thomas, The Journal of Experimental Medicine HistocompatibilityHla ImmunogeneticsImmunologyHumoral ResponseImmunodominance	1993	101

Page 1